FWCGX | MWEFX | FWCGX / MWEFX | |
Total Expense Ratio | 0.47 | 1.15 | 41% |
Annual Report Gross Expense Ratio | 0.47 | 1.18 | 40% |
Fund Existence | 5 years | 32 years | - |
Gain YTD | 9.155 | 6.143 | 149% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 131B | 2.18B | 6,001% |
Annual Yield % from dividends | 1.81 | 0.74 | 246% |
Returns for 1 year | 6.64 | -4.19 | -159% |
Returns for 3 years | 46.75 | 2.05 | 2,281% |
Returns for 5 years | N/A | 9.19 | - |
Returns for 10 years | N/A | 29.56 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTCX | 20.46 | -0.13 | -0.63% |
Fidelity Advisor Biotechnology C | |||
AZNCX | 9.52 | -0.06 | -0.63% |
Virtus Income & Growth C | |||
MSBVX | 11.93 | -0.15 | -1.24% |
Morgan Stanley American Resilience I | |||
NCIGX | 30.98 | -0.41 | -1.31% |
Nuveen International Value C | |||
MNHWX | 26.13 | -0.41 | -1.54% |
Manning & Napier Pro-Blend Max Term W |